• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定、海洋衍生吲哚咔唑的结构-活性关系,以及具有强大抗胰腺癌功效的双重 PKCθ/δ 抑制剂。

Identification, Structure-Activity Relationships of Marine-Derived Indolocarbazoles, and a Dual PKCθ/δ Inhibitor with Potent Antipancreatic Cancer Efficacy.

机构信息

Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University, No. 1 Zheda Road, Zhoushan 316021, China.

College of Life and Environmental Sciences, Hangzhou Normal University, No. 2318, Yuhangtang Road, Hangzhou 311121, China.

出版信息

J Med Chem. 2020 Nov 12;63(21):12978-12991. doi: 10.1021/acs.jmedchem.0c01271. Epub 2020 Oct 25.

DOI:10.1021/acs.jmedchem.0c01271
PMID:33100009
Abstract

Protein kinases C (PKCs) are a family of serine/threonine kinases involved in various cellular processes, including proliferation, differentiation, cell survival, and apoptosis. Here, we report the identification, structure-activity relationship (SAR), and 3D-QSAR studies of 69 natural indolocarbazoles, including 15 new compounds, from marine streptomyces strains. Interestingly, we found that the chair conformational isomer of 7-oxo-staurosporine (compound ) inhibited PKCθ more potently than the corresponding boat isomer. An evaluation of kinase selectivity and antitumor efficacy revealed that was a potent dual PKCθ/δ inhibitor and that it could efficiently inhibit tumor growth in pancreatic cancer (PC) by inducing cellular apoptosis and suppressing the NF-κB/p-P65 pathway. In addition, we demonstrated that overexpression of p-PKCδ and p-P65 was associated with poor survival rates in patients with PC, and p-PKCθ expression also showed significant positive correlations with p-PKCδ and p-P65 levels. Finally, the PC patient-derived xenograft model further confirmed the potential anti-PC efficacy of .

摘要

蛋白激酶 C(PKCs)是一族丝氨酸/苏氨酸激酶,参与多种细胞过程,包括增殖、分化、细胞存活和细胞凋亡。在这里,我们报告了 69 种天然吲哚咔唑的鉴定、结构-活性关系(SAR)和三维定量构效关系(3D-QSAR)研究,这些化合物来自海洋链霉菌菌株,其中包括 15 种新化合物。有趣的是,我们发现 7-酮星孢菌素(化合物 )的椅式构象异构体比相应的船式异构体对 PKCθ 的抑制作用更强。对激酶选择性和抗肿瘤功效的评估表明,是一种有效的双重 PKCθ/δ 抑制剂,可通过诱导细胞凋亡和抑制 NF-κB/p-P65 通路有效地抑制胰腺癌(PC)的肿瘤生长。此外,我们证明了 p-PKCδ 和 p-P65 的过度表达与 PC 患者的生存率降低有关,并且 p-PKCθ 的表达也与 p-PKCδ 和 p-P65 的水平呈显著正相关。最后,PC 患者来源的异种移植模型进一步证实了化合物 对 PC 的潜在治疗效果。

相似文献

1
Identification, Structure-Activity Relationships of Marine-Derived Indolocarbazoles, and a Dual PKCθ/δ Inhibitor with Potent Antipancreatic Cancer Efficacy.鉴定、海洋衍生吲哚咔唑的结构-活性关系,以及具有强大抗胰腺癌功效的双重 PKCθ/δ 抑制剂。
J Med Chem. 2020 Nov 12;63(21):12978-12991. doi: 10.1021/acs.jmedchem.0c01271. Epub 2020 Oct 25.
2
Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.通过基于药效团的设计、3D-QSAR 和针对阿尔茨海默病的分子动力学模拟来鉴定潜在的蛋白激酶 C 抑制剂。
J Biomol Struct Dyn. 2018 Nov;36(15):4029-4044. doi: 10.1080/07391102.2017.1406824. Epub 2017 Dec 13.
3
Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005.发现选择性蛋白激酶 C-θ 激酶抑制剂 CC-90005。
J Med Chem. 2021 Aug 26;64(16):11886-11903. doi: 10.1021/acs.jmedchem.1c00388. Epub 2021 Aug 6.
4
A novel 2,4-diaminopyrimidine derivative as selective inhibitor of protein kinase C theta prevents allograft rejection in a rat heart transplant model.一种新型的 2,4-二氨基嘧啶衍生物作为蛋白激酶 Cθ的选择性抑制剂可预防大鼠心脏移植模型中的移植物排斥反应。
Bioorg Med Chem. 2018 Nov 1;26(20):5499-5509. doi: 10.1016/j.bmc.2018.09.029. Epub 2018 Sep 24.
5
Investigating small molecules to inhibit germinal center kinase-like kinase (GLK/MAP4K3) upstream of PKCθ phosphorylation: Potential therapy to modulate T cell dependent immunity.研究小分子抑制生发中心激酶样激酶(GLK/MAP4K3)上游的 PKCθ磷酸化:调节 T 细胞依赖性免疫的潜在治疗方法。
Bioorg Med Chem Lett. 2018 Jun 1;28(10):1964-1971. doi: 10.1016/j.bmcl.2018.03.032. Epub 2018 Mar 26.
6
Bioactive staurosporine derivatives from the Streptomyces sp. NB-A13.从链霉菌属 NB-A13 中分离得到的生物活性司替罗星衍生物。
Bioorg Chem. 2019 Feb;82:33-40. doi: 10.1016/j.bioorg.2018.09.016. Epub 2018 Sep 21.
7
Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles.通过糖基化吲哚咔唑的组合生物合成产生强效和选择性激酶抑制剂。
Chem Commun (Camb). 2009 Jul 21(27):4118-20. doi: 10.1039/b905068j. Epub 2009 May 27.
8
Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo.蛋白激酶 C-δ 失活可抑制培养和体内的肿瘤干细胞的增殖和存活。
BMC Cancer. 2014 Feb 14;14:90. doi: 10.1186/1471-2407-14-90.
9
First generation 5-vinyl-3-pyridinecarbonitrile PKCtheta inhibitors.第一代 5-乙烯基-3-吡啶甲腈 PKCθ 抑制剂。
Bioorg Med Chem Lett. 2009 Oct 15;19(20):5829-32. doi: 10.1016/j.bmcl.2009.08.086. Epub 2009 Aug 29.
10
Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors.一系列4-芳基氨基-3-吡啶甲腈作为蛋白激酶Cθ(PKCθ)抑制剂的鉴定、表征及初步的从苗头化合物到先导化合物的优化
J Med Chem. 2008 Oct 9;51(19):5958-63. doi: 10.1021/jm800214a. Epub 2008 Sep 11.

引用本文的文献

1
Discovery of novel STAT3 inhibitors with anti-breast cancer activity: structure-based virtual screening, molecular dynamics and biological evaluation.具有抗乳腺癌活性的新型STAT3抑制剂的发现:基于结构的虚拟筛选、分子动力学和生物学评价
RSC Med Chem. 2025 Apr 7. doi: 10.1039/d5md00053j.
2
Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer.海洋类 Staurosporine 类似物:三阴性乳腺癌中的活性和靶标鉴定。
Mar Drugs. 2024 Oct 5;22(10):459. doi: 10.3390/md22100459.
3
Cheminformatics-Guided Exploration of Synthetic Marine Natural Product-Inspired Brominated Indole-3-Glyoxylamides and Their Potentials for Drug Discovery.
基于 cheminformatics 的合成海洋天然产物启发的溴化吲哚-3-糖氧酰胺的探索及其在药物发现中的潜力。
Molecules. 2024 Aug 1;29(15):3648. doi: 10.3390/molecules29153648.
4
Generation of streptocarbazoles with cytotoxicities by pathway engineering and insights into their biosynthesis.通过途径工程生成具有细胞毒性的链孢囊菌素及其生物合成的见解。
Appl Environ Microbiol. 2024 Mar 20;90(3):e0218723. doi: 10.1128/aem.02187-23. Epub 2024 Feb 2.
5
Discovery of the allosteric inhibitor from actinomyces metabolites to target EGFR mutant protein: molecular modeling and free energy approach.从放线菌代谢产物中发现针对 EGFR 突变蛋白的变构抑制剂:分子建模和自由能方法。
Sci Rep. 2023 Jun 1;13(1):8885. doi: 10.1038/s41598-023-33065-7.
6
PKCδ promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway.蛋白激酶Cδ通过c-myc/神经分化相关蛋白1途径促进结直肠癌的侵袭和迁移。
Front Oncol. 2023 Feb 2;13:1026561. doi: 10.3389/fonc.2023.1026561. eCollection 2023.
7
Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer.蛋白激酶C(PKC)同工酶作为癌症的诊断和预后生物标志物及治疗靶点
Cancers (Basel). 2022 Nov 3;14(21):5425. doi: 10.3390/cancers14215425.
8
Inhibitors targeting the autophosphorylation of serine/threonine kinase of show potent antimicrobial activity.靶向丝氨酸/苏氨酸激酶自身磷酸化的抑制剂具有强大的抗菌活性。
Front Microbiol. 2022 Sep 2;13:990091. doi: 10.3389/fmicb.2022.990091. eCollection 2022.
9
Anticancer effects of marine compounds blocking the nuclear factor kappa B signaling pathway.海洋化合物通过阻断核因子 κB 信号通路发挥抗癌作用。
Mol Biol Rep. 2022 Oct;49(10):9975-9995. doi: 10.1007/s11033-022-07556-1. Epub 2022 Jun 8.
10
The Emerging Function of PKCtheta in Cancer.蛋白激酶Cθ在癌症中的新功能
Biomolecules. 2021 Feb 5;11(2):221. doi: 10.3390/biom11020221.